Clarifying the debate over therapeutic forgetting

American Journal of Bioethics

Volumn 7, Issue 9, 2007, Pages 25-27

  Kolber, Adam ^a  

^a UNIVERSITY OF SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADVISORY COMMITTEE; BIOETHICS; DRUG EFFECT; HUMAN; MEMORY; NOTE; POSTTRAUMATIC STRESS DISORDER; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; ADVISORY COMMITTEES; BIOETHICAL ISSUES; ETHICS COMMITTEES; HUMANS; MEMORY; PROPRANOLOL; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES;

EID: 34548569494     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160701518508     Document Type: Note

References (6)

1. Craigie, J. 2007. Propranolol, cognitive biases, and practical decision-making. American Journal of Bioethics (AJOB-Neuroscience) 7(9): 31-33.
2. Henry, M., J. R. Fishman, and S. J. Youngner. 2007. Propranolol and the prevention of post-traumatic stress disorder: is it wrong to erase the "sting" of bad memories? American Journal of Bioethics (AJOB-Neuroscience) 7(9): 12-20.
3. Kolber, A. J. 2006. Therapeutic forgetting: The legal and ethical implications of memory dampening. Vanderbilt Law Review 59(5): 1561-1626.
4. Laub, G. 2006. Beyond wounds. Guilt & Pleasure 2:46-69.
5. Lisa, 2005. Posting to CogNews. Available at http://cognews.com/ 1072217907/index_html (accessed July 1, 2007).
6. President's Council on Bioethics. 2003. Beyond therapy: Biotechnology and the pursuit of happiness. Washington, DC: Government Printing Office.